Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Lindskog

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Case Reports in Oncology|October 30, 2024
Immunotherapy and Tyrosine Kinase Inhibitor as a Bridge to Surgery for Clear Cell Renal Cell Carcinoma Metastases to the Thyroid: A Case Report and Literature ReviewRobert Bränström, Jan Zedenius, Ivan Shabo, et al.
Leukemia & Lymphoma|October 6, 2010
Fish oil delays lymphoma progression in the TLL mouseAnn-Sofie Johansson, Ulrika Norén-Nyström, Asa Larefalk, et al.
Clinical Chemistry|January 1, 2003
Quantitative analysis of tyrosine hydroxylase mRNA for sensitive detection of neuroblastoma cells in blood and bone marrowCatarina Träger, Per Kogner, Magnus Lindskog, et al.
BMC Palliative Care|July 18, 2024
Fluid therapy is associated with lower care quality and higher symptom burden during last days of life of patients with cancer - a population-based register studyMagnus Lindskog, Hanna Mogensen, Björn Tavelin, et al.
International Journal of Cancer|December 15, 2005
Neuroblastoma cell death in response to docosahexaenoic acid: sensitization to chemotherapy and arsenic-induced oxidative stressMagnus Lindskog, Helena Gleissman, Frida Ponthan, et al.
Acta Oncologica (Stockholm, Sweden)|January 12, 2019
Cancer patients hospitalised in the last week of life risk insufficient care quality - a population-based study from the Swedish Register of Palliative CareSixten Elmstedt, Hanna Mogensen, Dan-Erik Hallmans, et al.
Acta Oncologica (Stockholm, Sweden)|December 4, 2018
Metastatic papillary renal cell carcinoma in the era of targeted therapy - a retrospective study from three European academic centresMaria Stenman, Michael Staehler, Bernadett Szabados, et al.
International Journal of Cancer|May 26, 2010
Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivoHelena Gleissman, Lova Segerström, Mats Hamberg, et al.
Leukemia & Lymphoma|June 27, 2009
Lymphoblastic T-cell lymphoma in mice is unaffected by Celecoxib as single agent or in combination with cyclophosphamideAnn-Sofie Johansson, Sven-Christian Pawelzik, Asa Larefalk, et al.
Urologic Oncology|June 18, 2017
Overall survival in Swedish patients with renal cell carcinoma treated in the period 2002 to 2012: Update of the RENCOMP study with subgroup analysis of the synchronous metastatic and elderly populationsMagnus Lindskog, Thomas Wahlgren, Rickard Sandin, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Case Reports in Oncology|October 30, 2024
Immunotherapy and Tyrosine Kinase Inhibitor as a Bridge to Surgery for Clear Cell Renal Cell Carcinoma Metastases to the Thyroid: A Case Report and Literature ReviewRobert Bränström, Jan Zedenius, Ivan Shabo, et al.
Leukemia & Lymphoma|October 6, 2010
Fish oil delays lymphoma progression in the TLL mouseAnn-Sofie Johansson, Ulrika Norén-Nyström, Asa Larefalk, et al.
Clinical Chemistry|January 1, 2003
Quantitative analysis of tyrosine hydroxylase mRNA for sensitive detection of neuroblastoma cells in blood and bone marrowCatarina Träger, Per Kogner, Magnus Lindskog, et al.
BMC Palliative Care|July 18, 2024
Fluid therapy is associated with lower care quality and higher symptom burden during last days of life of patients with cancer - a population-based register studyMagnus Lindskog, Hanna Mogensen, Björn Tavelin, et al.
International Journal of Cancer|December 15, 2005
Neuroblastoma cell death in response to docosahexaenoic acid: sensitization to chemotherapy and arsenic-induced oxidative stressMagnus Lindskog, Helena Gleissman, Frida Ponthan, et al.
Acta Oncologica (Stockholm, Sweden)|January 12, 2019
Cancer patients hospitalised in the last week of life risk insufficient care quality - a population-based study from the Swedish Register of Palliative CareSixten Elmstedt, Hanna Mogensen, Dan-Erik Hallmans, et al.
Acta Oncologica (Stockholm, Sweden)|December 4, 2018
Metastatic papillary renal cell carcinoma in the era of targeted therapy - a retrospective study from three European academic centresMaria Stenman, Michael Staehler, Bernadett Szabados, et al.
International Journal of Cancer|May 26, 2010
Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivoHelena Gleissman, Lova Segerström, Mats Hamberg, et al.
Leukemia & Lymphoma|June 27, 2009
Lymphoblastic T-cell lymphoma in mice is unaffected by Celecoxib as single agent or in combination with cyclophosphamideAnn-Sofie Johansson, Sven-Christian Pawelzik, Asa Larefalk, et al.
Urologic Oncology|June 18, 2017
Overall survival in Swedish patients with renal cell carcinoma treated in the period 2002 to 2012: Update of the RENCOMP study with subgroup analysis of the synchronous metastatic and elderly populationsMagnus Lindskog, Thomas Wahlgren, Rickard Sandin, et al.
Pageof 5